Mercury Computer Systems Inc. today announced a cooperation agreement with the Germany-based Institute of Medical Physics for the development and commercialization of medical imaging technology deployed on the Cell Broadband Engine (BE) processor. The joint work is expected to accelerate the reconstruction and visualization of medical imaging data, as preliminary results show 100-times improvement in computed tomography (CT) reconstruction, Mercury officials said.

Toshiba America Medical Systems, Inc. announced today a new partnership with CVCTA Education and San Francisco Advanced Medical Imaging, a Liberty Pacific Medical Imaging Company, to serve as the company’s newest education and training partner, as part of its plan to deliver a cardiac CT training program to the medical community.

A pair of Georgia-based groups, Cardiovascular Medicine and Quantum Radiology, have announced the formation of a clinical research site that specializes in conducting Phase II-IV studies. Known as InnovaMed Alliance, the multidisciplinary collaboration is working with the healthcare industry to provide patients with access to novel therapies.

RADinfo Systems has announced plans to introduce its PACS solution for mammography, known as Micro PowerPACS Mammography, during the Radiological Society of North America’s annual conference in Chicago next week. With more and more hospitals and imaging centers looking to expand into digital mammography technology, RADinfo is touting its new Micro PowerPACS as an affordable yet high-quality digital imaging option.

New research suggests that men with prostate cancer who choose radiation therapy should seek treatment centers that will offer high-dose radiation. A new study from Fox Chase Cancer Center finds that higher doses of 74 to 82 Gray (Gy) greatly reduce the risk that the cancer will spread later — even 8-10 years after treatment.

In one of the first studies to compare side effects of IMRT and permanent prostate brachytherapy (I-125) for treatment of low-risk prostate cancer, researchers say patients had fewer moderate and serious side effects when treated with IMRT.
"Both treatments demonstrated excellent PSA outcomes (biochemical control) after treatment," said Thomas N. Eade, MBChB, a fellow in the department of radiation oncology at Fox Chase Cancer Center. "The patients who received IMRT tended to be older, but even with that factor, IMRT was better tolerated."

Cedara has announced that it will demonstrate at RSNA its new C4 integration platform, a system that allows OEM companies to integrate clinical applications into existing solutions, responding to the need to unify multiple PACS installations across the enterprise.

David B. Nash, M.D., MBA, FACP and editor of the American Journal of Medical Quality will unveil a groundbreaking supplement with three peer-reviewed articles about hospital-acquired infections in the National Press Club (Murrow Room), 529 14th Street, NW, Washington, DC on November 20, from 10 a.m. to 11 a.m.

According to a report from Breast Center Salzburg published in the International Journal of Cancer, radiation administered during surgery, directly at the site of the excised tumor, greatly reduces the incidence of ipsilateral (same side) breast tumor recurrence. The findings were delivered by Dr. Felix Sedlmayer, chairman of Radiation Oncology at the University of Salzburg, on Oct. 8 at a special meeting of the European Chapter of the International Society of IORT.

According to the Fox Chase Cancer Center study presented at the recent 48th Annual Meeting of the American Society for Therapeutic Radiology and Oncology, external-beam radiation therapy for early-stage breast cancer can be delivered safely and in a shorter course that eliminates as much as two weeks from conventional treatment.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now